Critical Conversations in SOF: Brain Injury Risk and Reality

For patients managing chronic conditions, the appeal of implantable drug delivery is easy to understand: a device placed once, delivering medication precisely where it's needed, for months or years at a time. It's a compelling vision—and for some patients, it's already a reality. For many others, it remains just out of reach.

In Special Operations, cognitive performance is not incidental. It is operational.

Neurotechnology is reaching a turning point, moving from breakthrough research to real‑world impact. In this conversation, Justin Sanchez explores how non‑invasive, wearable neurotech is reshaping rehabilitation, human‑machine interaction, and the future of restoring communication through the nervous system.

MedTech companies are buying their way to innovation. Pharma and biotech are building networks to share the load. Both are responding to the same forces—rising R&D costs, regulatory complexity and pressure to move faster with less—but the strategies couldn't look more different.

A MedTech startup came to us with a promising wound-management concept, early IP and a working prototype. From their perspective, they had already solved the hardest problem. But as we dug in, a different reality emerged.